FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/070306 [Registered on: 09/07/2024] Trial Registered Prospectively
Last Modified On: 15/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Nasal spray in sinusitis and cold 
Scientific Title of Study   To study the efficacy of Kalingadi Arka nasal spray in Kaphaja prathishyaya( Chronic rhinosinusitis) An open labelled randomized controlled clinical study  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vidya R E 
Designation  Post graduate Resident 
Affiliation  SDM institute of Ayurveda and Hospital 
Address  Room no-16, Department of Shalakya tantra, SDM institute of Ayurveda, Anchepalya, Bengaluru, Karnataka

Bangalore
KARNATAKA
560074
India 
Phone  76191659348  
Fax    
Email  vidyakumbar27@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mamatha K V  
Designation  Professor and Head of the department  
Affiliation  SDM institute of Ayurveda and Hospital 
Address  room no 16, Department of shalakya tantra, SDM institute of Ayurveda, Anchepalya, Bengaluru, karnataka
SDM institute of Ayurveda, Anchepalya, Bengaluru, Karnataka
Bangalore
KARNATAKA
560074
India 
Phone  76191659348  
Fax    
Email  mail2mamatha@sdmayurbangalore.in  
 
Details of Contact Person
Public Query
 
Name  Dr Mamatha K V  
Designation  Professor and Head of the department  
Affiliation  SDM institute of Ayurveda and Hospital 
Address  room no 16, Department of shalakya tantra, SDM institute of Ayurveda, Anchepalya, Bengaluru, karnataka
SDM institute of Ayurveda, Anchepalya, Bengaluru, Karnataka
Bangalore
KARNATAKA
560074
India 
Phone  76191659348  
Fax    
Email  mail2mamatha@sdmayurbangalore.in  
 
Source of Monetary or Material Support  
SDM institute of Ayurveda and hospital, Anchepalya, Bengaluru,560074 
 
Primary Sponsor  
Name  Dr VIDYA R E 
Address  SDM institute of Ayurveda and hospital, Anchepalya, Bengaluru, Karnataka-560074 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mamatha K V  SDM institute of Ayurveda and Hospital  Room no-16, Department of Shalakya tantra, SDM institute of Ayurveda and Hospital, Anchepalya, Bengaluru, Karnataka-560074
Bangalore
KARNATAKA 
9845393236

mail2mamatha@sdmayurbangalore.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Sri Dharmasthala manjunatheshwara institute of Ayurveda and Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:J310||Chronic rhinitis. Ayurveda Condition: PRATISYAYAH/PINASAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Kalingadi Arka Nasal spray , Reference: Yogarathnakara Nasarogachikitsa adhyaya, verse no 43, Route: Nasal, Dosage Form: Arka, Dose: 0.05(ml), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Kalingadi taila, Reference: Chakradatta, Nasarogadhikara 58/8, Route: Nasal, Dosage Form: Taila, Dose: 8(drops), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  1.Patients with clinical features of Kaphaja Prathishyaya (chronic rhinosinusitis)
2.Subjects fit for Nasya karma
3.Patient of either sex, with age group between 20-40 years
4.Patients with chronicity less than 5year
 
 
ExclusionCriteria 
Details  1. Patients with any other systemic disorders (like TB, HIV, Retro positive diabetes, Hypertension and Thyroid.) that may interfere the course of treatment
2. Any associated conditions like migraine headache, referred pain from dental pathology will be excluded
3. Patients with nasal polyps along with rhinosinusitis will not be considered for the study
4. Patients suffering from Chronic Simple Rhinitis associated with tonsillitis, adenoids
5. Patients of gross DNS being the reason for nasal blockage
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1.Nasa srava (Nasal discharge)
2.Pratisthabdam (Nasal obstruction)
3.Gala, Oshta, Talu kanduyana (Itching throat, palate and lips)
4.Mukhashiro guruthva (Heaviness of Face and Head)
5.Aruchi (Anorexia)
6.Nasanaha (Oedema of the middle meatus)
7.Shirashoola (Headache)
 
15 DAYS 
 
Secondary Outcome  
Outcome  TimePoints 
1.Sustained effect of treatment on Subjective Parameters

2.Improvement changes in SNOT-22 questionnaire.

3.To develop easily approachable cost-effective treatment
 
15 DAYS 
1.Sustained effect of treatment on Subjective Parameters

2.Improvement changes in SNOT-22 questionnaire.

3.To develop easily approachable cost-effective treatment
 
15 DAYS 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   19/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="5"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Patients of Chronic rhinosinusitis tend to use nasal spray more often due to its simple convenient and easily applicable nasal delivery system. Thus, as per the practicality and quest for such treatment modalities in Ayurveda. Arka is adopted in the form of nasal spray which is prepared by combination of Jala and Agni which makes the medicaments laghupaki, vyavayi, vikasi and thus assimilating quickly in the body, in the present study the drugs of Kalingadi avapeeda nasya will be formulated to Arka as a new ideology and will be administered to patients in the form of nasal spray which will be economical and beneficial

 
 
Close